Climate Change Trends and Their Impact on the Seasonal Upper Respiratory Tract Disease Burden

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBarzilai Medical Center

About this trial

Investigators assume that global climate changes can influence upper respiratory tract infection peak prevalence, which may have significant clinical implication, for example, by adjusting seasonal Influenzas' vaccine timing. Therefore, the investigators will collect data from electronic medical database about patients tested positive for winter seasonal respiratory tract viruses from 2022 and compare the incidence to the meteorological profile of that season.

Eligibility criteria

Qualifiers

All patient with a positive nasopharyngeal swab for a respiratory virus

Disqualifiers

No medical record available

Trial design

Treatments tested in this trial

  • No Intervention: Observational Cohort

Treatment groups

5,000 Participants
are divided into 1 treatment group

Sponsors and collaborators